| Enrolling By Invitation | TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate Chronic Hepatitis B | Phase 1 / Phase 2 | 2025-06-12 |
| Recruiting | Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Anti Vertical Human Immunodeficiency Virus Transmission, HIV Infection Pediatric, Infant Death | — | 2024-04-30 |
| Unknown | BTZ-043 Dose Evaluation in Combination and Selection Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis | Phase 2 | 2023-09-21 |
| Recruiting | PanACEA - STEP2C -01 Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | Phase 2 | 2023-04-14 |
| Recruiting | SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia SARS CoV 2 Infection, COVID-19 Breakthrough, COVID-19 Recurrent | — | 2022-11-10 |
| Completed | Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory | Phase 1 | 2021-10-08 |
| Completed | PanACEA Sutezolid Dose-finding and Combination Evaluation Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | Phase 2 | 2021-05-06 |
| Unknown | Early Risk Assessment in Household Contacts (≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Co Tuberculosis | — | 2021-03-01 |
| Completed | BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis | Phase 1 / Phase 2 | 2019-11-15 |
| Completed | Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE HIV, Neonatal HIV Early-Infant-Diagnosis (EID), Point-of-Care Testing (PoC) | — | 2019-10-23 |
| Completed | Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) Tuberculosis, Diagnoses Disease | — | 2019-01-21 |
| Completed | A Single Ascending Dose Study of BTZ043 Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections | Phase 1 | 2018-06-07 |
| Unknown | Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania. HIV/AIDS | — | 2017-10-15 |
| Completed | HIV Point-of-Care Test Evaluation in Infants HIV | N/A | 2015-07-01 |
| Completed | A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensar Tuberculosis | — | 2015-03-01 |
| Completed | Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique Tuberculosis | — | 2014-06-01 |
| Completed | Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MA Tuberculosis, Pulmonary | Phase 2 | 2013-04-01 |
| Completed | A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses o HIV-1 Infection | Phase 2 | 2012-12-01 |
| Completed | Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB Tuberculosis, Pulmonary | Phase 2 | 2010-11-01 |